eXoZymes, Inc.
EXOZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.12 | -0.73 | -3.78 | 0.00 |
| FCF Yield | -6.64% | -2.09% | -2.05% | -2.86% |
| EV / EBITDA | -22.48 | -44.92 | -59.38 | -61.30 |
| Quality | ||||
| ROIC | -49.72% | -131.28% | -60.68% | -62.19% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.45 | 0.58 | 0.90 | 1.31 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | -100.00% | -100.00% |
| Free Cash Flow Growth | -505.76% | -1.84% | 28.18% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.49 | -0.97 | -0.04 | -0.15 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,261.69 | 0.00 | -953.06 | -1,642.34 |